Cytokinetics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 05/15/2026 | 17.52 M | $1.15 B | -1.09% | 14.36% |
| BLACKROCK, INC. | 05/13/2026 | 16.55 M | $1.09 B | 0.93% | 13.56% |
| FMR LLC | 05/15/2026 | 10.72 M | $706.76 M | -16.28% | 8.79% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/15/2026 | 8.01 M | $527.91 M | 0.91% | 6.56% |
| 05/08/2026 | 5.84 M | $385.16 M | 100.00% | 4.79% | |
| STATE STREET CORP | 05/15/2026 | 5.75 M | $378.67 M | -1.38% | 4.71% |
| 05/15/2026 | 5.49 M | $361.76 M | 100.00% | 4.50% | |
| AVORO CAPITAL ADVISORS LLC | 05/15/2026 | 3.33 M | $219.70 M | 100.00% | 2.73% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 3.22 M | $211.97 M | 5.22% | 2.64% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 3.13 M | $206.00 M | 6.27% | 2.56% |
| RTW INVESTMENTS, LP | 05/15/2026 | 2.72 M | $179.35 M | 0.00% | 2.23% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 2.21 M | $145.38 M | -7.00% | 1.81% |
| UBS GROUP AG | 05/05/2026 | 2.08 M | $136.91 M | 83.59% | 1.70% |
| ARMISTICE CAPITAL, LLC | 05/15/2026 | 1.70 M | $112.05 M | 13.33% | 1.39% |
| POLAR CAPITAL HOLDINGS PLC | 05/15/2026 | 1.66 M | $109.49 M | -31.43% | 1.36% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 05/15/2026 | 1.60 M | $105.46 M | 14.29% | 1.31% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 1.58 M | $104.42 M | -17.92% | 1.30% |
| MORGAN STANLEY | 05/15/2026 | 1.51 M | $99.20 M | 18.95% | 1.23% |
| PARADIGM BIOCAPITAL ADVISORS LP | 05/15/2026 | 1.48 M | $97.60 M | 100.00% | 1.21% |
| NORTHERN TRUST CORP | 05/14/2026 | 1.44 M | $95.02 M | 4.41% | 1.18% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 1.40 M | $92.08 M | 0.98% | 1.14% |
| DEEP TRACK CAPITAL, LP | 05/15/2026 | 1.37 M | $90.58 M | -58.82% | 1.13% |
| CAPITAL INTERNATIONAL INVESTORS | 05/13/2026 | 1.34 M | $88.24 M | 13.58% | 1.10% |
| CAPTION MANAGEMENT, LLC | 05/15/2026 | 1.23 M | $81.07 M | 152.93% | 1.01% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2026 | 1.16 M | $76.45 M | 24.10% | 0.95% |
| CITADEL ADVISORS LLC | 05/15/2026 | 1.10 M | $72.49 M | -5.42% | 0.90% |
| PRINCIPAL FINANCIAL GROUP INC | 05/04/2026 | 1.09 M | $72.07 M | 11.94% | 0.90% |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 05/08/2026 | 1.09 M | $71.68 M | 100.00% | 0.89% |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 1.01 M | $66.32 M | 17.78% | 0.82% |
| WOODLINE PARTNERS LP | 05/15/2026 | 1.00 M | $65.94 M | -39.31% | 0.82% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 05/15/2026 | 1.00 M | $65.91 M | 100.00% | 0.82% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 994.80 K | $65.57 M | -30.34% | 0.82% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2026 | 992.55 K | $65.42 M | 100.00% | 0.81% |
| 05/14/2026 | 980.39 K | $64.62 M | 0.00% | 0.80% | |
| JPMORGAN CHASE & CO | 05/13/2026 | 903.81 K | $56.91 M | -36.03% | 0.74% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 898.95 K | $59.25 M | 19.28% | 0.74% |
| LOGOS GLOBAL MANAGEMENT LP | 05/15/2026 | 875.00 K | $57.67 M | 191.67% | 0.72% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 854.37 K | $56.31 M | 47.34% | 0.70% |
| MELQART ASSET MANAGEMENT (UK) LTD | 05/12/2026 | 843.95 K | $55.62 M | 35.49% | 0.69% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 799.62 K | $52.70 M | 100.00% | 0.66% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 779.45 K | $51.37 M | 45.07% | 0.64% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 05/13/2026 | 771.00 K | $50.82 M | 100.00% | 0.63% |
| FISHER ASSET MANAGEMENT, LLC | 05/05/2026 | 768.26 K | $50.64 M | -6.64% | 0.63% |
| ARMISTICE CAPITAL, LLC | 05/15/2026 | 764.54 K | $50.39 M | -22.99% | 0.63% |
| PICTET ASSET MANAGEMENT HOLDING SA | 04/22/2026 | 750.95 K | $49.30 M | -0.87% | 0.62% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 05/14/2026 | 714.34 K | $47.08 M | -13.71% | 0.59% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 706.63 K | $46.57 M | 492.71% | 0.58% |
| AFFINITY ASSET ADVISORS, LLC | 05/14/2026 | 700.48 K | $46.17 M | -12.44% | 0.57% |
| FEDERATED HERMES, INC. | 05/11/2026 | 699.45 K | $46.10 M | 44.61% | 0.57% |
| NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. | 05/12/2026 | 660.31 K | $43.52 M | -11.72% | 0.54% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cytokinetics Inc institutional Ownership - FAQ's
During the previous two years, 582 institutional investors and hedge funds held shares of Cytokinetics Inc. The most heavily invested institutionals were:
T. Rowe Price Investment Management, Inc.: 17.52 M
BlackRock, Inc.: 16.55 M
FMR LLC: 10.72 M
WELLINGTON MANAGEMENT GROUP LLP: 8.01 M
STATE STREET CORP: 5.75 M
Avoro Capital Advisors LLC: 3.33 M
121.71% of Cytokinetics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 183.12 M shares in the last 24 months. This purchase volume represents approximately $11.43 B in transactions.